4.7 Editorial Material

Exploring the therapeutic space around NAD+

期刊

JOURNAL OF CELL BIOLOGY
卷 199, 期 2, 页码 205-209

出版社

ROCKEFELLER UNIV PRESS
DOI: 10.1083/jcb.201207019

关键词

-

资金

  1. AMC
  2. Ecole Polytechnique Federale de Lausanne
  3. EU [ERC-2008-AdG-23118]
  4. Velux Stiftung
  5. Swiss National Science Foundation [31003A-124713, CRSII3-136201]
  6. Swiss National Science Foundation (SNF) [31003A_124713, CRSII3_136201] Funding Source: Swiss National Science Foundation (SNF)

向作者/读者索取更多资源

NAD(+) is a central metabolite in the cell. Changes in NAD(+) abundance and the activity of NAD(+)-dependent enzymes, such as the sirtuins, are at the core of metabolic/mitochondrial diseases, such as obesity and diabetes, and of cancer and neurodegeneration. Here, we discuss how maintaining or raising NAD(+) levels can improve metabolism and prevent age-related functional decline and associated disease, and how basic scientific discoveries in the NAD(+) signaling pathway are being translated to the clinic.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据